The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients

MLA

Liesbeth Geerligs, et al. “The Value of Real-World Testing: A Qualitative Feasibility Study to Explore Staff and Organisational Barriers and Strategies to Support Implementation of a Clinical Pathway for the Management of Anxiety and Depression in Adult Cancer Patients.” Pilot and Feasibility Studies, vol. 6, no. 1, July 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s40814-020-00648-4.

APA

Liesbeth Geerligs, Heather L. Shepherd, Nicole M. Rankin, Lindy Masya, Joanne M. Shaw, Melanie A. Price, Haryana Dhillon, Colette Dolan, Gabrielle Prest, The ADAPT Program Group, & Phyllis Butow. (2020). The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients. Pilot and Feasibility Studies, 6(1), 1–10. https://doi.org/10.1186/s40814-020-00648-4

Chicago

Liesbeth Geerligs, Heather L. Shepherd, Nicole M. Rankin, Lindy Masya, Joanne M. Shaw, Melanie A. Price, Haryana Dhillon, et al. 2020. “The Value of Real-World Testing: A Qualitative Feasibility Study to Explore Staff and Organisational Barriers and Strategies to Support Implementation of a Clinical Pathway for the Management of Anxiety and Depression in Adult Cancer Patients.” Pilot and Feasibility Studies 6 (1): 1–10. doi:10.1186/s40814-020-00648-4.